Firms Slam Fresh Price Cut Threats

September 2006 | Company Finance Alert

Smaller German drugmakers have opposed any further government moves to cut medicines costs, following deep reductions in generic drug prices in recent months. Germany's mid-sized pharmaceutical companies have witnessed a frenzy of M&A activity in recent weeks, at a time when the so-called Economic Optimization of Pharmaceutical Care Act (AVWG) is introducing harsh cost cuts..

If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.